Giovana Marssola Nascimento

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Multidrug Resistant

Cystic Fibrosis

Top Venues

Infectious diseases and therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)
Beatriz Arns, Jaqueline Driemeyer Correia Horvath, Gabriela Soares Rech, Guilhermo Prates Sesin, Crepin Aziz Jose Oluwafoumi Agani, Bruna Silveira da Rosa, Tiago Marcon Dos Santos, Liliane Spencer Bittencourt Brochier, Alexandre Biasi Cavalcanti, Bruno Martins Tomazini, Adriano Pereira Paglia, Viviane Cordeiro Veiga, Giovana Marssola Nascimento, Andre C Kalil, Alexandre Prehn Zavascki
A Randomized, Open-Label, Non-inferiority Clinical Trial Assessing 7 Versus 14 Days of Antimicrobial Therapy for Severe Multidrug-Resistant Gram-Negative Bacterial Infections: The OPTIMISE Trial Protocol. Infectious diseases and therapy 13 (1) (2023)